🔗 Permalink

Inventor profile of:

Bin Wang

City:

Dallas, Texas

Country:

United States

Published Applications:

Last publication date:

2026-02-12

Top Assignees for applications by Bin Wang

The entities that hold a legal rights for patent applications filed by inventor Wang Bin:

Peloton Therapeutics, Inc. 11 Dallas, TX United States
TheRas, Inc. 1 South San Francisco, CA United States
ARRAY BIOPHARMA INC. 1 Boulder, CO United States
LEIDOS BIOMEDICAL RESEARCH, INC. 1 Frederick, MD United States
Peloton Therapeutics, Inc. 1 Kenilworth, NJ United States
Lawrence Livermore National Security, LLC 1 Livermore, CA United States

Recent patent applications by Wang Bin

Bin Wang from Dallas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-12

US20260042764A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF KRAS

#2 | 2026-02-05

US20260035376A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF RAS

#3 | 2025-08-28

US20250270225A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF RAS

#4 | 2025-08-28

US20250270206A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF RAS

#5 | 2025-07-17

US20250230138A1

Chemistry; metallurgy

COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS

#6 | 2025-06-12

US20250188085A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF RAS

#7 | 2025-03-13

US20250084079A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF RAS

#8 | 2024-09-12

US20240300964A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF RAS

#9 | 2024-07-25

US20240246954A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING KRAS

#10 | 2024-03-21

US20240092739A1

Chemistry; metallurgy

COMPOUNDS AND METHODS OF USE

#11 | 2021-10-14

US20210317150A1

Chemistry; metallurgy

CD73 inhibitors and uses thereof

#12 | 2021-08-19

US20210253614A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING CD73

#13 | 2020-06-18

US20200190031A1

Chemistry; metallurgy

ARYL ETHERS AND USES THEREOF

#14 | 2020-04-16

US20200115404A1

Chemistry; metallurgy

CD73 INHIBITORS AND USES THEREOF

#15 | 2019-04-25

US20190119214A1

Chemistry; metallurgy

Aryl ethers and uses thereof

#16 | 2019-01-17

US20190015377A1

Human necessities

Compositions for Use in Treating Pulmonary Arterial Hypertension

#17 | 2018-06-14

US20180162807A1

Chemistry; metallurgy

Aromatic compounds and uses thereof

#18 | 2018-06-07

US20180155279A1

Chemistry; metallurgy

Aryl ethers and uses thereof

#19 | 2018-02-22

US20180049995A1

Human necessities

HIF-2-ALPHA INHIBITOR POLYMORPHS

#20 | 2017-08-03

US20170217892A1

Chemistry; metallurgy

Aryl ethers and uses thereof

#21 | 2017-08-03

US20170217891A1

Chemistry; metallurgy

Aryl ethers and uses thereof

#22 | 2017-03-30

US20170088523A1

Chemistry; metallurgy

Benzimidazole derivatives and uses thereof

#23 | 2016-12-22

US20160368893A1

Chemistry; metallurgy

Cyclic sulfone and sulfoximine analogs and uses thereof

#24 | 2016-09-01

US20160251307A1

Chemistry; metallurgy

Aryl ethers and uses thereof

#25 | 2014-01-02

US20140005213A1

Chemistry; metallurgy

Triazolopyridine compounds as PIM kinase inhibitors

InventorID:

597441 ⎘